Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, October 1999, p. 2513-2516, Vol. 43, No. 10
Eijkman-Winkler Institute, Utrecht
University, 3584 CX, Utrecht, The Netherlands,1
and Institute for Medical Microbiology and Virology,
Received 30 March 1999/Returned for modification 28 June
1999/Accepted 27 July 1999
The parC and gyrA genes of 73 ciprofloxacin-resistant and 6 ciprofloxacin-susceptible
Enterococcus faecium clinical isolates were partly
sequenced. Alterations in ParC and GyrA, possibly in combination with
other resistance mechanisms, severely restricted the in vitro
activities of the nine quinolones tested. For all isolates,
clinafloxacin and sitafloxacin showed the best activities.
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Association of Alterations in ParC and GyrA
Proteins with Resistance of Clinical Isolates of Enterococcus
faecium to Nine Different Fluoroquinolones
*
Corresponding author. Mailing address: Eijkman-Winkler
Institute, Utrecht University, AZU G04.614, Heidelberglaan 100, 3585 CX, Utrecht, The Netherlands. Phone: 31 30 250-7625. Fax: 31 30 254-1770. E-mail: sbrisse{at}lab.azu.nl.
Antimicrobial Agents and Chemotherapy, October 1999, p. 2513-2516, Vol. 43, No. 10
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»